Market News Archive
Stay updated with the latest announcements
DSE NEWS: Regarding Lodging Investor Complaints through CCAM
The Investors are requested to lodge their complaints against the TREC Holder Companies and the issuer of listed securities (if any) of DSE through Customer Complaint Address Module (CCAM) (link: https://www.cdbl.com.bd/complaints.sec.gov.bd/) for addressing their complaints virtually.
DSE NEWS: Awareness message
DSE NEWS: All Stock Dealers, Stock Brokers and Authorized Representatives are asked to strictly follow the code of conduct as enumerated in the Second Schedule to the Securities and Exchange Commission (Stock Dealer, Stock Broker and Authorized Representative) Rules, 2000.
DSE NEWS: Awareness Message for Investors
DSE does not publish market data through any social media pages. INVESTORS should not rely on any information from an unauthorized source such as Facebook, WhatsApp, Viber, Linkedin etc. (cont.)
BSEC NEWS: Awareness Message for Investors
Investors are requested to consider the following facts at the time of making investment decision in the Capital Market: 1. Without acquiring proper knowledge, information and experience regarding different aspects and matters of Capital Market, one should not invest in the Capital Market. 2. The gain or loss, whichever comes from the investment, it belongs to you. So, well - thought of investment decision based on knowledge and fundamentals of the securities may be real assistance to you. (cont.)
DSE NEWS: Greetings Message
Honorable Investors, Good morning! Please make your investment decision based on Company fundamentals, technical analysis, price level and disclosed information. Avoid rumor-based speculations.
DSE NEWS: Daily Turnover of Main Board
Today's (07.01.2025) Total Trades: 127,188; Volume: 171,488,262 and Turnover: Tk. 4,275.886 million.
FASFIN: Qualified Opinion, Emphasis of Matter and Other Matter
The auditor of the company has given the "Qualified Opinion", "Emphasis of Matter" and "Other Matter" paragraphs in the Auditor's Report of the company for the year ended December 31, 2023. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/FASFIN_2024.pdf
APOLOISPAT: Qualified Opinion, Going Concern and Other Matter
The auditor of the company has given the "Qualified Opinion", "Going Concern" and "Other Matter" paragraphs in the Auditor's Report of the company for the year ended June 30, 2021. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/APPOLLOISPAT_2024.pdf
STANCERAM: Qualified Opinion and Emphasis of Matter
The auditor of the company has given the "Qualified Opinion" and "Emphasis of Matter" paragraphs in the Auditor's Report of the company for the year ended June 30, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/STANCERAM_2024.pdf
MIRACLEIND: Qualified Opinion and Emphasis of Matters
The auditor of the company has given the "Qualified Opinion" and "Emphasis of Matters" paragraphs in the Auditor's Report of the company for the year ended June 30, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/MIRACLEIND_2024.pdf
DSSL: Emphasis of Matters
The auditor of the company has given the "Emphasis of Matters" paragraphs in the Auditor's Report of the company for the year ended June 30, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/DSSL_2024.pdf
LRBDL: Emphasis of Matter
The auditor of the company has given the "Emphasis of Matter" paragraphs in the Auditor's Report of the company for the year ended June 30, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/LUBRREF_2024.pdf
RENATA: Renata PLC's First Shipment of Risperidone to the U.S. Market
The company has informed that it has successfully dispatched its first consignment of Risperidone to the USA. Manufactured at Renata's U.S. FDA-approved facility in Bangladesh, Sperid has earned a reputation as a trusted solution for managing psychiatric disorders in the country. The initial shipment of 12 million tablets in 0.25 mg, 0.5 mg, and 1 mg strengths ensures precise dosing, essential for treating schizophrenia, bipolar disorder, and autism-related irritability.
TB5Y0128: Suspension for Record Date
Trading of 05Y BGTB 11/01/2028 Government Securities will be suspended on record date i.e., 09.01.2025 and day before the record date i.e., 08.01.2025 Trading of the Government Securities will resume on 12.01.2025.
TB15Y0128: Record date for entitlement of coupon payment
Record date for entitlement of coupon payment of 15Y BGTB 16/01/2028 Government Securities is 15.01.2025.
GEMINISEA: Resumption after Record Date
Trading of the shares of the company will resume on 08.01.2025.
DACCADYE: Resumption after Record Date
Trading of the shares of the company will resume on 08.01.2025.
AL-HAJTEX: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 08.01.2025.
CONFIDCEM: Spot for EGM
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 08.01.2025 to 09.01.2025 and trading of the shares will remain suspended on record date i.e., 12.01.2025 for EGM.
POWERGRID: Time extension for submission of annual audited financial statements
The company has informed that BSEC has approved their application regarding time extension up to January 30, 2025 for submission of annual audited financial statements for the year ended on June 30, 2024.